Summary
Many years preclinical and clinical anatomic, pharmacologic, and physiologic studies suggest that SP- and opioid-expressing neurons produce opposite biological effects at the spinal level, i.e., nociception and antinociception, respectively. However, in certain circumstances intrathecally administered SP is capable of reinforcing of spinal morphine analgesia and may therefore function as an opioid adjuvantin vivo. The SP dose-response curve of spinally administered SP follows a bell-shaped or inverted-U configuration, permitting pharmacological dissociation of opioid-potentiating and analgesic properties of SP from traditional hyperalgesic effects seen at significantly higher concentrations. This analgesic effect is blocked by naloxone but unaffected by transection of the spinal cord, thus demonstrating the lack of supraspinal modulation. The present report briefly describes both reinforcing and opposing interactions between multiple opioid systems and substance P at the spinal level. We propose that a likely mechanism underlying SP-mediated enhancement of opioid analgesia is the ability of SP to release endogenous opioid peptides within the local spinal cord environment.
Similar content being viewed by others
References
Carr, D.B. and Cousins, M.J., In Cousins, M.J. and Bridenbaugh, P.O. (Eds.) Lippincott Raven, New York, NY, 1997 (in press).
Lipkowski, A. W. and Carr, D.B., In Gutte, B. (Ed.) Academic Press, New York, NY, 1995, pp. 287–320.
Garret, C., Carruette, A., Fardin, V., Moussaoui, S., Peyronel, J.F., Blanchard, J.C. and Laduron, P.M., Proc. Natl. Acad. Sci. USA, 88 (1991) 10208.
Hylden, J.L.K. and Wilcox, G.L., J. Pharmacol. Exp. Ther., 226 (1983) 398.
Fredrickson, R.C.A., Burgis, V., Harrell, C.E. and Edwards, J.D., Science, 199 (1978) 1359.
Goettl, V.M. and Larson, A.A., Neuroscience, 60 (1994) 375.
Stewart, J.M., Getto, C.J., Neldner, K., Reeve, E.B., Krivoy, W.A. and Zimmermann, E., Nature, 262 (1976) 784.
Lipkowski, A.W., Konecka, A.M., Sroczynska, I., Przewlocki, R., Stala, L. and Tam, S.W., Life Sci., 40 (1987) 2283.
Misterek, K., Maszczynska, I., Dorociak, A., Gumulka, S.W., Carr, D.B., Szyfelbein, S.K. and Lipkowski, A.W., Life Sci., 54 (1994) 939.
Lipkowski, A.W., Carr, D.B., Misicka, A. and Misterek, K., In Brantl, B. and Teschemacher, H. (Eds.) VCH Weinheim, New York, NY, 1994, pp. 113–118.
Kream, R.M., Kato, T., Shimonaka, H., Marchand, J.E. and Wurm, W.H., Proc. Natl. Acad. Sci. USA, 90 (1993) 3564.
Yaksh, T.L. and Rudy, T.A., Phys. Behav., 17 (1976) 1031.
Cho, H.J. and Basbaum, A.I., J. Comp. Neurol., 281 (1989) 193.
Glazer, E.J. and Basbaum, A.I., Neuroscience, 10 (1983) 357.
LaMotte, C.C. and de Lanerolle, N.C., Brain Res., 274 (1983) 51.
Lei, S.Z., Lipkowski, A.W. and Wilcox, G.L., Eur. J. Pharmacol., 193 (1991) 209.
Skilling, S.R., Smullin, D.H. and Larson, A.A., J. Neurosci., 10 (1990) 1309.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maszczynska, I., Lipkowski, A.W., Carr, D.B. et al. Alternative forms of interaction of substance P and opioids in nociceptive transmission. Lett Pept Sci 5, 395–398 (1998). https://doi.org/10.1007/BF02443494
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02443494